C/EBPβ represses p53 to promote cell survival downstream of DNA damage independent of oncogenic Ras and p19Arf
- 18 July 2008
- journal article
- research article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 15 (11) , 1734-1744
Abstract
CCAAT/enhancer-binding protein-β (C/EBPβ) is a mediator of cell survival and tumorigenesis. When C/EBPβ−/− mice are treated with carcinogens that produce oncogenic Ras mutations in keratinocytes, they respond with abnormally elevated keratinocyte apoptosis and a block in skin tumorigenesis. Although this aberrant carcinogen-induced apoptosis results from abnormal upregulation of p53, it is not known whether upregulated p53 results from oncogenic Ras and its ability to induce p19Arf and/or activate DNA-damage response pathways or from direct carcinogen-induced DNA damage. We report that p19Arf is dramatically elevated in C/EBPβ−/− epidermis and that C/EBPβ represses a p19Arf promoter reporter. To determine whether p19Arf is responsible for the proapoptotic phenotype in C/EBPβ−/− mice, C/EBPβ−/−;p19Arf−/− mice were generated. C/EBPβ−/−;p19Arf−/− mice responded to carcinogen treatment with increased p53 and apoptosis, indicating p19Arf is not essential. To ascertain whether oncogenic Ras activation induces aberrant p53 and apoptosis in C/EBPβ−/− epidermis, we generated K14-ER:Ras;C/EBPβ−/− mice. Oncogenic Ras activation induced by 4-hydroxytamoxifen did not produce increased p53 or apoptosis. Finally, when C/EBPβ−/− mice were treated with differing types of DNA-damaging agents, including alkylating chemotherapeutic agents, they displayed aberrant levels of p53 and apoptosis. These results indicate that C/EBPβ represses p53 to promote cell survival downstream of DNA damage and suggest that inhibition of C/EBPβ may be a target for cancer cotherapy to increase the efficacy of alkylating chemotherapeutic agents.Keywords
This publication has 40 references indexed in Scilit:
- C/EBPβ Participates in Regulating Transcription of the p53 Gene in Response to Mitogen StimulationJournal of Biological Chemistry, 2007
- Coping with stress: multiple ways to activate p53Oncogene, 2007
- Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and Bcl2A1 as critical target genesJournal of Clinical Investigation, 2006
- Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for allNature Reviews Molecular Cell Biology, 2006
- Divorcing ARF and p53: an unsettled caseNature Reviews Cancer, 2006
- Decreased survival of C/EBPβ-deficient keratinocytes is due to aberrant regulation of p53 levels and functionOncogene, 2006
- Evidence that error-prone DNA repair converts dibenzo[a,l]pyrene-induced depurinating lesions into mutations: formation, clonal proliferation and regression of initiated cells carrying H-ras oncogene mutations in early preneoplasiaMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2000
- Cellular SenescenceCell, 2000
- The α2 and α5 integrin genes: identification of transcription factors that regulate promoter activity in epidermal keratinocytesFEBS Letters, 2000
- Regulation of a Senescence Checkpoint Response by the E2F1 Transcription Factor and p14 ARF Tumor SuppressorMolecular and Cellular Biology, 2000